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PURPOSE. Little is known about the signaling mechanisms controlling meibomian gland (MG)
homeostasis and the pathogenic processes leading to MG atrophy and dysfunction in dry eye
disease (DED). We investigated the role of fibroblast growth factor receptor 2 (FGFR2) in the
MG homeostasis of adult mice.
METHODS. A triple transgenic mouse strain (Krt14-rtTA; tetO-Cre; Fgfr2flox/flox), referred to as
Fgfr2CKO mice, was generated in which the Fgfr2 gene is ablated by Cre recombinase in
keratin 14 (Krt14)-expressing epithelial cells on doxycycline (Dox) induction. FGFR2
expression in normal human and mouse MGs was evaluated by immunohistochemistry.
Pathologic MG changes in transgenic mice with conditional deletion of FGFR2 were examined
by lipid staining, histology, and immunostaining.
RESULTS. FGFR2 was highly expressed in normal human MGs and adult mouse MGs. Two-
month-old Fgfr2CKO mice fed Dox-containing chow for 2 weeks developed severe MG
atrophy. MG acinar atrophy in the Fgfr2CKO mice was associated with reduced lipid (meibum)
production and the development of clinical findings similar to those in humans with
evaporative DED related to MG dysfunction (MGD). Immunohistochemical analyses showed
that FGFR2 deletion severely affected proliferation and differentiation of MG acinar cells but
affected MG ductal cells to a lesser extent.
CONCLUSIONS. FGFR2 deletion results in significant MG acinar atrophy and clinical manifestations
of MGD in Fgfr2CKO mice, suggesting that MG homeostasis is FGFR2 dependent. The Fgfr2CKO
mice with inducible MG atrophy can serve as a valuable animal model for investigating the
pathogenesis of MGD and developing novel therapeutic strategies for MGD-related DED.
Keywords: meibomian gland dysfunction, FGFR2, dry eye disease, meibomian gland atrophy,
knockout animals
Dry eye disease (DED) is a multifactorial disease character-ized by ocular surface desiccation and related ocular
irritation. The prevalence of DED is estimated to be 7% to 34% of
the US population, and the number of affected persons is
increasing with the aging of our population.1–3 The hallmark of
DED is tear film instability, caused by a reduction of aqueous tear
secretion, and an increase in tear evaporation, either alone or in
combination.1,4 The most common cause of evaporative DED is
meibomian gland dysfunction (MGD), which is associated with a
decrease in the quantity and/or quality of lipids in tear film.5,6
Meibomian glands (MGs), which are embedded in the tarsal
plates of the eyelids, synthesize and secrete a mixture of lipids,
termed ‘‘meibum,’’ which is spread over the eye surface during
blinking.7 Meibum constitutes the outer layer of tear film and
overlies the aqueous and mucin gels produced by the lacrimal
glands and conjunctival goblet cells, respectively. As such,
meibum plays a critical role in slowing the evaporation of tear
fluids, protecting the ocular surface from desiccating stress, and
enhancing tear film stability by lowering the surface tension of
tears.7,8 Despite the high prevalence of MGD among patients
with DED, our understanding of the pathogenesis of MGD
remains extremely limited, which undoubtedly has hampered
the development of effective therapeutics to ameliorate MGD or
restore the various MG functions. Current MGD therapies are
mostly palliative and unsatisfactory, as they often aim primarily at
symptomatic relief of DED and not directly at remediating the
underlying pathogenesis of MGD.9,10 To facilitate the develop-
ment of therapeutic approaches that target the pathogenic
mechanisms of MGD and produce a long-lasting improvement in
MG functions, it is of paramount importance to understand the
molecular mechanisms that modulate MG homeostasis and help
maintain tear film stability.
MGs are considered large and modified sebaceous glands
(SGs).11 MGs and SGs share common glandular characteristics,
including their holocrine secretion of lipids, by which the
terminally differentiated acinar epithelial cells disintegrate them-
selves to release the intracellular lipids.12 Prior studies of
immortalized sebocytes (acinar epithelial cells of the sebaceous
glands) have shown that several types of cell surface receptors,
including those for peptides, sex hormones, neurotransmitters,
and growth factors, are expressed in sebocytes, suggesting that SG
homeostasis is likely to be regulated by some of these receptors.13
It is well known that fibroblast growth factor receptors
(FGFRs) and their ligands participate in embryonic and
postnatal development and regulate cell proliferation, survival,
migration, and differentiation in adult mice.14–16 In mammals,
there are 22 FGF ligands that can signal via one or more of the
four FGFRs. Among the four Fgfr genes (Fgfr1–4), Fgfr1–3
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genes contain alternative splicing sites at the C-terminal IgIII
domain, resulting in two isoforms known as Fgfrb and Fgfrc.
An in vivo mouse genetic study showed that conditional gene
deletion of one of the isoforms of FGFR2, namely Fgfr2b, in
epidermal cells, causes striking abnormalities in hairs and SGs
without affecting animal survival.14 These findings suggest that
FGFR2b signaling activity is required for the normal develop-
ment and homeostasis of SGs.
Very little is known about the signaling pathways that
regulate MG homeostasis.13,14,17 Specifically, the role of FGFR2
and its related ligands in MG development and homeostasis has
not been explored. To determine whether FGFR2 signaling is
crucial for MG homeostasis in mice, we used an inducible
conditional gene knockout strategy to delete Fgfr2 in keratin
14 (Krt14)-expressing epithelial cells and generated a mouse
model of MG atrophy inducible with doxycline (Dox) (Krt14-
rtTA; tetO-Cre; Fgfr2flox/flox, referred as Fgfr2CKO) (Fig. 1).
Herein, we describe the histopathologic features of MG
atrophy in this triple-transgenic mouse strain and demonstrate
for the first time that the induced loss of FGFR2 (both b and c
isoforms) in 2-month old mice leads to severe MG atrophy,
substantiating that FGFR2 plays a pivotal role in MG
homeostasis and tissue maintenance. To the best of our
knowledge, this mouse model constitutes the first animal
model of inducible MG atrophy, phenotypically resembling MG
atrophy in human MGD-related DED. Our findings also suggest
that the Fgfr2CKO mouse model of Dox-induced MG atrophy
can serve as a valuable tool for delineating the pathogenic
mechanisms of MGD and for evaluating potential therapeutic
interventions for MGD-related DED.
MATERIALS AND METHODS
Acquisition of Donor Eyelid Tissues
Tarsal plates removed from fresh cadaver’s upper and lower
eyelids of a healthy Caucasian female donor (36 years of age)
were obtained from Mid-America Transplant (St. Louis, MO,
USA). The use of human tissue in research conformed to the
provisions of the Declaration of Helsinki and was exempted by
the Washington University Human Subjects Protection Office.
Prior to removal of eye tissues, medical and ocular histories of
the donor had been deidentified and reviewed to ensure no
evident ocular or systemic diseases. The removal of donor
eyelid tissues and corneas was performed under a standard
protocol for procurement of ocular tissues.
Mouse Strains and Genotyping
All transgenic mice were bred at the Animal Science Research
Center of the University of Missouri (Columbia, MO, USA).
Animal experiments were conducted in accordance with the
institutional guidelines on the Care, Welfare and Treatment of
Laboratory Animals, and the protocols were approved by the
University of Missouri Institutional Animal Care and Use
Committee. The experiments conformed to the standards in
the ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research. Transgene alleles were screened by PCR using
tail DNA, following the conditions and primer pairs recom-
mended for JAX mice (Krt14-rtTA stock#008099 and tetO-Cre
stock#006224) and previously reported for Fgfr2-flox mice.18,19
Generation of Conditional Knockout Mice on Dox
Administration
Compound transgenic mice of K14rtTA-tetOCre-Fgfr2fl/fl were
generated via natural mating following the scheme illustrated
in Figure 1. In this deletion system, Cre expression in Krt14-
(or K14)-expressing cells can be initially induced in mice of any
age by systemic administration of Dox, and consequently the
floxed Fgfr2 is ablated by Cre recombinase (Fig. 1). In our
study, conditional knockout of Fgfr2 was induced in 2-month-
old adult mice by ad libitum Dox chow feeding, for 4 days to 2
weeks, at the dosage of 1 g Dox/kg chow (Dox diet #AD3008;
Custom Animal Diets, Bangor, PA, USA). Littermates fed with
regular chow without Dox served as control animals.
Oil-Red-O Staining for Lipids
Fresh mouse eyelids were collected from transgenic and
control mice, immediately fixed with 4% paraformaldehyde
FIGURE 1. Schematic of Dox-induced conditional deletion of Fgfr2 gene. Double transgenic mice (K14rtTA-tetOCre) were created to express Cre
recombinase, on Dox induction, in epithelial cells that express Krt14 promoters. The double transgenic mice were then bred to Fgfr2flox/flox mice to
generate triple transgenic mice (K14rtTA-tetOCre-Fgfr2 fl/fl). Ablation of Fgfr2 in K14-expressing cells is induced by feeding the triple transgenic
mice Dox chow for various lengths of time.
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overnight, and rinsed with PBS. For Oil-Red-O (ORO) staining
of the eyelid whole mount, eyelids were placed in 60% 2-
propanol for 15 minutes, stained with ORO solution for 30
minutes, and then destained with 60% 2-propanol for 15 to 30
minutes to achieve optimal lipid staining over the background
color. For ORO staining on cryosections, eyelid tissues were
embedded in OCT and sectioned at 10 lm of thickness. Frozen
sections were placed in 60% 2-propanol for 1 minute, stained
with ORO solution for 15 minutes, rinsed with PBS, and
counterstained with hematoxylin.
Histology
Mouse eyes with eyelids were dissected, fixed overnight in 4%
paraformaldehyde (PFA) in PBS, and then processed for
embedding in paraffin. Tissue sections (5 lm) were deparaffi-
nized with xylene, rehydrated with ethanol, and stained with
either hematoxylin and eosin (H&E) or periodic acid-Schiff
(PAS) reagent per the manufacturer’s instructions.
5-Bromo-2 0-Deoxyuridine Incorporation Assay
5-Bromo-20-deoxyuridine (BrdU), 0.1 mg/g of body weight, was
injected intraperitoneally and labeled for 2 hours before mice
were euthanized. BrdU immunostaining was performed follow-
ing the conditions previously described by Fromm et al.20
Immunofluorescence and Immunohistochemistry
Paraffin sections were deparaffinized in xylene, rehydrated in a
decreased ethanol series, and subjected to antigen retrieval in 10
mM sodium citrate buffer by boiling for 10 minutes.21,22 Sections
were treated with 3% hydrogen peroxide in PBS for 20 minutes to
block endogenous peroxidase activity. Cyrosections (7 lm) were
dipped in PBS to remove OCT, fixed with 4% PFA for 10 minutes,
and then rinsed with PBS three times. Tissue sections were
blocked with 3% horse serum in PBST (PBS plus 0.1% Tween-20
for paraffin sections) or PBS plus 0.5% Triton X-100 (for
cryosections) for 1 hour at room temperature and then incubated
overnight at 48C, with primary antibodies diluted in the same
buffer. Slides were washed with PBS, incubated at room
temperature for 1 hour with either fluorophore-conjugated or
biotinylated secondary antibodies, and then washed with PBS. For
immunofluorescence, cell nuclei were stained with 40,6-diamidi-
no-2-phenylindole (DAPI), and slides were mounted with Mowiol
(Sanofi-Aventis, Bridgewater, NJ, USA) for viewing under a Leica
microscope equipped with a charge-coupled device (CCD)
camera for photography. For immunohistochemistry, sections
were incubated with Vectastain Elite ABC Reagent (PK-6100;
Vector Laboratories, Burlingame, CA, USA), and color was
developed by using 3,3 0-diaminobenzidine as a substrate
(D4293; Sigma-Aldrich Corp., St Louis, MO, USA). Sections were
counterstained with hematoxylin for cell nuclei.
Primary antibodies were purchased from the following
sources: anti-FGFR2 (ab10648; Abcam, Cambridge, MA, USA);
anti-keratin 10 and anti-keratin 14 (PRB-159P and PRB-155P,
respectively; Covance, Emeryville, CA, USA); anti-keratin 16
(NBP2-45538; Novusbio, Littleton, CO, USA); anti-p63
(GTX102425, GeneTex, Irvine, CA, USA), anti-PPARc (#2435; Cell
Signaling, Danvers, MA, USA); anti-PCNA (ab29; Abcam); and anti-
BrdU (M-0744; Dako, Carpinteria, CA, USA). Fluorophore-
conjugated secondary antibodies were obtained from Thermo-
Fisher Scientific (Rockford, IL, USA) and biotinylated secondary
antibodies were from Vector Laboratories.
Statistical Analysis
For quantitative analysis of BrdU index in MG ductal epithelial
cells, two eyelids of different mice were excised from either
control or Fgfr2CKO fed with Dox for 6 days. A minimal of four
cross sections along a MG central duct and a minimal of six ducts
on each section were included in analyses. Data were expressed
as mean 6 SEM, and P values were calculated using paired
Student’s t-tests, with P < 0.05 being significant.
RESULTS
FGFR2 Expression in Human and Mouse MGs
To investigate the importance of FGFR2 in MG homeostasis, we
first examined FGFR2 expression patterns in the tarsal plate of
human and mouse eyelids. We noted high FGFR2 levels were
expressed in both acinar and ductal epithelial cells of human and
mouse MGs (Fig. 2). The finding of mouse MGs having a similar
FGFR2 expression pattern to that of human MGs suggests that
FGFR2 signaling is required for MG homeostasis in both species,
similar to what has been reported in mouse SGs.14
MG Atrophy as a Result of Fgfr2 Conditional
Deletion on Dox Induction
Conditional deletion mediated by keratin 5 (Krt5) promoter
has shown that FGFR2b is required for SG homeostasis in the
skin of adult mice.14 However, to our knowledge, the role of
FGFR2 in MG homeostasis has never been investigated in that
FIGURE 2. FGFR2 expression in normal human and mouse MGs
detected by immunohistochemistry. (A) In human MG, FGFR2 is
expressed in the acini (a), ductules (d), and central duct (D). In the
peripheral MG acinus, FGFR2 immunoreactivity was detected in both
the cell membrane and nuclei of basal epithelial cells (black arrow)
and in newly differentiated meibocytes (white arrow). (B) In mouse
MG, the FGFR2 expression pattern was similar to that seen in human
MG (A). Scale bars denote 100 lm.
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mouse model. Keratin 14 (Krt14) is a keratin pair of Krt5 and is
known to be expressed in various ocular surface epithelial
tissues, including MGs.21 To investigate whether FGFR2 plays a
role in MG homeostasis, we generated a triple transgenic
mouse model (Krt14TA-tetOCre-Fgfr2fl/fl), as depicted in Figure
1, in which conditional deletion of Fgfr2 only occurs via
activation of Krt14 promoter on Dox feeding. At 2 months of
age, the mice were fed either regular chow (control mice) or
Dox chow (Fgfr2 conditional knockout or Fgfr2CKO mice). The
triple transgenic mice fed with regular chow display no evident
MG pathologies but develop MG atrophy on feeding with Dox-
containing chow. After 7 to 10 days of Dox chow feeding,
Fgfr2CKO mice were reluctant to keep their eyes open wide
and showed symptoms of ocular irritation. With extended Dox
feeding (14 days), more advanced symptoms were noted, with
macerated periorbital hairs and eyelids, suggesting excessive
eye rubbing due to ocular irritation (Fig. 3). Control mice did
not exhibit such symptoms. Lipid (meibum) production by
MGs in the upper eyelids was assessed by eyelid whole mounts
stained with ORO In control mice, meibum was seen in the
central duct, but in Fgfr2CKO mice, a reduction of meibum
staining in the central duct and a reduction in MG acinar size
were visible (compare Fig. 3A with 3B). These findings suggest
that FGFR2 signaling is essential for MG function and
homeostasis in adult mice. The results further indicate that
we have created a mouse model with inducible MG atrophy
that causes ocular symptoms similar to those of MGD in
humans.
Histologic examination of MG atrophy after 1 week of Dox
feeding revealed a moderate reduction in the number of MG
acini in Fgfr2CKO mice compared with the number of MG acini
in control mice (Fig. 4). The conjunctival and corneal epithelia
looked similar in control and Fgfr2CKO mice. Immunostainings
of mucin 5AC (Muc5AC) as a goblet cell marker and of Krt13 as
a conjunctival epithelial marker (Supplementary Fig. S1)
further substantiated the aforementioned findings. After 2
weeks of Dox feeding, Fgfr2CKO mice had developed severe
MG atrophy. However, PAS staining revealed no discernible
difference in goblet cell density between control and Fgfr2CKO
mice. In contrast to the conjunctival epithelium, the corneal
epithelial layer after 2 weeks of Dox feeding appeared to be
thinner in Fgfr2CKO mice than in control mice (Figs. 4C, 4D).
Cross sections of the upper eyelids of Fgfr2CKO and control
mice were stained with ORO to correlate reduced meibum
production with the morphologic and histologic changes of
MG atrophy (Figs. 4E, 4F). Lipid staining confirmed that MG
atrophy in Fgfr2CKO mice was associated with a severe
decrease in acinar size and a reduction of meibum volume in
the central duct. The results suggest that the degree of MG
atrophy in this mouse model can be modulated by the duration
of Dox feeding.
To evaluate the efficiency of Dox induced gene deletion, we
examined the levels of Cre and FGFR2 in the eyelids of control
and Fgfr2CKO mice (Supplementary Fig. S2). After 4 days of
Dox feeding, Cre was expressed in most MG acinar cell nuclei
but with variable amounts (Supplementary Fig. S2B). The
expression of Cre in ductal cells was delayed, but high levels
were detected after 6 days of Dox feeding (Supplementary Fig.
S2C). In response to Cre expression, FGFR2 level was reduced
significantly in the MG acini of FGFR2CKO mice fed with Dox
chow compared with that in control mice (Supplementary
FIGURE 3. MG atrophy and signs of DED in Fgfr2CKO mice. (A, B) ORO
lipid staining in control and Fgfr2CKO mice. Upper eyelids were
dissected from control mice (fed regular chow) and Fgfr2CKO mice (fed
Dox chow for 10 days) and subjected for whole-mount ORO staining to
view lipid (meibum) production by MG acini (arrows labeled a).
Meibum secreted into main duct (arrowhead labeled d) was stained in
a dark-red color in control mice (A). Compared with control mice,
Fgfr2CKO mice exhibited a reduction of MG acinar area and meibum
production (B). (C, D) Compared with control mice (C), Fgfr2CKO mice
showed signs of ocular irritation, including loss of corneal luster and
macerated eyelids, after extended (2 to 3 weeks) Dox chow feeding
(D). Such signs of ocular irritation were likely due to increased tear
evaporation and tear film instability.
FIGURE 4. Histology of eyelid and ocular surface tissues in Fgfr2CKO
and control mice. (A, B) H&E staining of frontal sections from control
(no Dox) and Fgfr2CKO mice after 1 week of Dox feeding, showing a
moderate reduction in the number of MG acini in mutant mice
compared with the number of MG acini in control mice (broken line
circled areas). The conjunctival (Conj) and corneal (Co) epithelium
(epi) looked similar in the control and Fgfr2CKO mice. (C, D) PAS
staining showed severe MG atrophy, with minimal acinar tissue, after 2
weeks of Dox feeding. There was no discernible difference in PAS-
positive goblet cells (gb, arrowheads) between control and Fgfr2CKO
mice. The thickness of the corneal epithelial layer (epi, arrows in D)
was significantly reduced in Fgfr2 deletion mice. (E, F) ORO staining of
cross sections of the upper eyelids in Fgfr2CKOand control mice
showing a reduction MG acinar size (labeled a) and a decrease in
meibum volume in the central duct (labeled d) in Fgfr2CKO mice fed
Dox chow for 10 days. Sections were counterstained with hematox-
ylin. M, muscle; HF, hair follicle.
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Figs. S2D–SE0). Immunofluorescence of FGFR2 was diminished
in both MG acinar and ductal cells but was still detectable in
the conjunctival epithelium of Fgfr2CKO mice after 10 days of
Dox induction (Supplementary Figs. S2F, S2F0).
To further evaluate the phenotype of MG atrophy in
Fgfr2CKO mice, we examined the immunofluorescence of
Krt14 expression in different MG structures, such as the
acinus, ductule, and the central duct (Fig. 5). As the diagram in
Figure 5 illustrates, cross sections of the upper eyelid in the
distal MG area and of the lower eyelid close to MG orifice were
selected to investigate any changes in acini around the ductules
and acini around central duct. MG acinar atrophy was readily
visible in Fgfr2CKO mice fed with Dox for 1 week compared
with the control mice. The ductal structures in mutant mice
were less affected than acinar tissue. The acellular area
(occupied by meibum) within the ductule or central duct
was reduced or nearly absent in Fgfr2CKO mice, a phenotype
consistent with reduced meibum synthesis and secretion and
ductal obstruction with exfoliated epithelial plugs known in
human MGD.
PPARc, Krt10, and Krt16 Expression by
Immunohistochemistry
In normal MGs, meibocytes within an MG acinus undergo a
pattern of differentiation, starting from undifferentiated
proliferating basal cells in the periphery and progressing to
suprabasal nucleated meibocytes that synthesize lipids. During
this differentiation process, peroxisome proliferator–activated
receptor gamma (PPARc), a lipid-activated hormone receptor
that regulates lipid synthesis, is up-regulated in newly
differentiated meibocytes and then down-regulated in mature
or terminally differentiated meibocytes.22,23 Compared with
control mice, Fgfr2CKO mice fed Dox chow for 1 week
exhibited a significant decrease in the number of PPARc-
positive meibocytes, which correlates with the finding of
acinar atrophy (Figs. 6A, 6B).
Normally, as meibocytes proceed through their usual
holocrine differentiation, the acinar cells increase in size as a
consequence of accumulating lipid droplets, and then rupture
and release their lipid cargo into the ductule space. Before the
lipid (meibum) in the central duct is delivered to the ocular
surface to form the outer layer of tear film, most of the cellular
remnants are disintegrated. In the control mice, this process
was evident by the lack of PPARc expression in mature
meibocytes with high lipid content inside the duct (Fig. 6A). In
Fgfr2CKO mice, the meibocytes in the central duct contained
more densely packed and nucleated cell debris, suggesting that
FGFR2 deletion inhibits differentiation and maturation of
meibocytes and disrupts the normal holocrine mechanism
(Fig. 6B).
To confirm the observation that ductal structures are less or
minimally affected compared with acini in Fgfr2CKO mice, we
examined by immunohistochemistry the expression of Krt16, a
marker for ductal epithelia (Figs. 6C, 6D). In control mice,
Krt16 was expressed at a much higher level in MG ductules
and central duct than in acini. In Fgfr2CKO mice, despite severe
MG acinar atrophy, the intensity of Krt16 immunostaining in
the ductal tissues was at a similar level as in control mice
(compare Fig. 6D with 6C). This result suggests that, in
contrast to MG acinar cells, ductal epithelial cells are not
significantly affected by FGFR2 deletion.
Jester et al.24 previously demonstrated that expression of
Krt1 (which pairs with Krt10) extends from the fully
keratinized epidermis (skin) into the ductal epithelium at the
MG orifice in young adult mice and that Krt1 expression
extends posteriorly toward the conjunctiva. Krt10 expression
in the MG central duct was also shown by Call et al.25 recently.
We found that Krt10 was expressed in ductal epithelial cells in
both control and Fgfr2CKO mice (Figs. 6E, 6F). However, the
central ducts of Fgfr2CKO mice showed a reduction of meibum
volume and an increase of cellular debris (Fig. 6F). These
results suggest that MG acinar cell differentiation and
maturation are FGFR2 dependent. In contrast, ductal epithelial
cells are not significantly affected by the loss of FGFR2.
Decrease of MG Basal Cells in Fgfr2CKO Mice
When apoptosis was examined by TUNEL assay, a few positive
nuclei (indicating apoptosis) were only found in the duct, but
not in the acini, in both control and Fgfr2CKO mice, suggesting
that MG atrophy in mutant mice is not caused by cell death
(data not shown). To further explore the pathogenic mecha-
nisms of MG atrophy in Fgfr2CKO mice, we examined the
FIGURE 5. Immunofluorescence of Krt14. Cross sections of the distal acinar area of the upper eyelid (A, B) and the central ductal area of lower
eyelid (C, D), as illustrated in the diagram on left, were examined for Krt14 immunofluorescence. (A, B) MG acinar atrophy was seen in Fgfr2CKO
mice fed with Dox for 7 days, as shown by the reduction of Krt14 staining compared with control mice. In contrast to acinar tissue, the ductal
structures in mutant mice were not affected significantly (compare areas marked by dotted lines in B and D versus A and C). (C, D) The acellular
area (occupied by meibum) within the ductule or central duct (white arrows, labeled d) can be readily seen in control mice, but is either visibly
reduced or nearly absent in Fgfr2CKO mice because of decreased meibum production.
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number of basal cells in MG acini using p63 as a marker.
Transcription factor p63 is a member of the p53 family and a
key regulator of epithelial cell fate.21,26–29 We found that basal
cell density in MG acini of Fgfr2CKO mice was largely reduced
after 4 days of Dox induction compared with the control mice
(compare Fig. 7A with 7B). We then investigated the
expression pattern of another cell proliferation marker,
proliferating cell nuclear antigen (PCNA) (Figs. 7C, 7D).
Immunofluorescence of PCNA (red) was colocalized with
Krt14 immunofluorescence (green) to demarcate the MGs in
eyelids. In control mice, PCNA-positive nuclei were found in
basal epithelial cells of MG acini and ducts, suggesting that
these cells are in the proliferative state. In Fgfr2CKO mice fed
Dox chow for 1 week, PCNA-positive nuclei were found in
ductal basal cells but rarely seen in acinar basal cells. We
further confirmed that cell proliferation in MG ductal
epithelium of Fgfr2CKO mice by colocalizing PCNA immuno-
fluorescence with Krt17. Krt17, similar to Krt 16 (as shown in
Figs. 6C, 6D), is also preferentially expressed in MG ductal cell
(Supplementary Fig. S3). Taken together, these results suggest
that FGFR2 deletion primarily inhibits proliferation of the MG
acinar basal cells.
BrdU incorporation assay was performed to examine the
effect of FGFR2 on cell cycle progression in MG acinar basal
cells (Figs. 7E, 7F). In control mice, BrdU-positive nuclei,
indicative of cells at S-phase of cell cycle, were found in the
basal cell layers of MG acini and in central ducts. Compared
with the control mice, a drastic reduction in BrdU-labeled cells
was noted in MG acini of Fgfr2CKO mice, suggesting that FGFR2
deletion blocks cell cycle progression in MG acinar basal cells.
In contrast, BrdU incorporation in the ductal basal cells of
Fgfr2CKO mice did not seem to be affected. The BrdU labeling
index in ductal epithelium was 7.31 6 0.65% in control and
5.90 6 0.55% in Fgfr2CKO (P¼ 0.08), indicating the difference
was not statistically significant. The findings of BrdU labeling
are consistent with those of PCNA immunofluorescence. Taken
together, our cell proliferation studies imply that FGFR2
FIGURE 6. PPARc, Krt10, and Krt16 expression in lower eyelids
detected by immunohistochemistry. (A) In control mice, within an
acinus, PPARc is not expressed in undifferentiated basal cells (small
arrow in A). PPARc expression (brown nuclear staining) is up-
regulated in differentiated meibocytes (large arrow) and then down-
regulated in mature meibocytes (white arrow). Meibocytes inside the
duct (labeled D; red broken-line circle) were negative for PPARc. (B) In
Fgfr2CKO mice fed with Dox chow for 1 week, MG acinar atrophy was
noted, with a reduction of PPARc-positive meibocytes in MG acinus.
Additionally, although ductal cells in mutant mice were PPARc
negative, they did not appear to be fully mature (as shown in the
nucleated cells inside red circle in Fig. 5B). (C, D) In both control and
Fgfr2CKO mice, Krt16 expression levels were higher in the ductules (d)
and main duct (labeled D) than in acini. Severe MG acinar atrophy was
seen in Fgfr2CKO mice, but ductal tissues looked intact. (E, F) Krt10
expression was found in cells within central duct (red broken-line
circles) in both control and Fgfr2CKO mice. In Fgfr2CKO mice, a
reduction of meibum volume and the presence of nucleated cell debris
were seen (F). HF, hair follicles.
FIGURE 7. Expression of basal and proliferating cell markers. (A, B)
Transcription factor p63 in MGs detected by immunohistochemistry on
crysections. The basal cells in MG acini (dark brown nuclei indicated
by arrows in A) and ducts (data not shown) express p63 (A). In
FGFR2CKO mice fed with Dox for 4 days, the number of basal cells
around the MG acini was markedly reduced (B). (C, D) Immunoflu-
orescence of Krt14 (green) and proliferative cell nuclear antigen
(PCNA) (red). Krt14 expression marks the areas of MGs in eyelids. In
control mice (C), intense PCNA immunofluorescence was found in
acinar (a) and ductal (d) basal epithelial cell nuclei (red as indicated by
white arrow in C), suggesting that these cells are in the proliferative
state. Within a MG acinus, PCNA immune intensity decreases when
basal cells are differentiated into meibocytes (arrowhead in C). In
Fgfr2CKO mice induced by Dox for 1 week, PCNA-positive nuclei were
rarely seen in acinar basal cells, but detected in ductal basal layer
(white broken-line circle in D). (E, F) BrdU-labeled cells were found in
MG acinar and ductal basal cell layer in control mice (arrows in E). In
Fgfg2CKO mice fed with Dox for 6 days, BrdU incorporation was seen in
MG ductal basal cells (arrows in F), but rarely detected in the acini. HF,
hair follicle.
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signaling is crucial for acinar basal cell proliferation to maintain
MG homeostasis in adult mice.
To explore the downstream signaling pathways of FGFR2,
we further examined the levels of ERK1/2 (or ERK) proteins
and their active form, the phosphorylated ERK (or pERK), in
the MGs of control and Fgfr2CKO mice fed with Dox for 4 days
(Supplementary Fig. S4). We found that ERK proteins were
present in both MG acinar and ductal cells in control mice
(Supplementary Figs. S4A, S4C), but pERK (the active form)
was mostly localized in the nuclei of MG acini. Despite MG
atrophy in Fgfr2CKO mice, pERK could still be found in the
nuclei of MG acinar cells of both control and Fgfr2CKO mice
(Supplementary Figs. S4B0, S4D0), suggesting that FGFR2 may
regulate MG basal cell proliferation via ERK-independent
pathways.
DISCUSSION
By definition, MGD is a chronic, diffuse MG abnormality,
commonly characterized by terminal duct obstruction and/or
qualitative/quantitative changes in glandular secretion.5,7,30
This condition may result in alterations of the tear film on the
ocular surface, symptoms of eye irritation, clinically apparent
inflammation, and ocular surface morbidities.2,31,32 MGD is the
leading cause of DED in the United States and elsewhere in the
developed world, affecting 5% to 30% of the population aged
50 or older.3,33 Age-related changes in human MGs include
primary acinar atrophy and/or inspissation of MG orifices
leading to decreased meibum secretion. MG atrophy and
dropout can apparently occur as early as 25 years of age, and
the extent of these pathogenic changes increases significantly
and approximately linearly with age.33 At present, the
underlying mechanism of age-related MG acinar atrophy is
poorly understood. In this study, we developed a novel mouse
model of inducible MG atrophy by conditional deletion of
FGFR2. We demonstrate for the first time in mice that FGFR2
plays an essential role in MG acinar maintenance and
homeostasis. Importantly, the observed MG atrophy in our
mouse model as a result of loss of FGFR2 is in striking
resemblance to age-related MG atrophy in humans.34 Because
FGFR2 proteins are present at high levels in both mouse and
human MGs (Fig. 1), our current findings thus imply that
reduced or altered FGFR2-signaling activity could be one of the
underlying mechanisms that lead to age-related MG acinar
atrophy and glandular dropouts in humans.
It is well known that the MG acinar cells (meibocytes)
secrete meibum via a holocrine mechanism.7,35 During this
secretion process, the meibocytes undergo a well-defined
program of cell differentiation and maturation, which can be
defined morphologically as undifferentiated (basal), differenti-
ating, mature, and hypermature meibocytes. A single MG
acinus consists of a contiguous layer of proliferative basal cells
in the acinar periphery that surrounds a cluster of lipid-filled
meibocytes undergoing differentiation and maturation.36 Lysis
of hypermature meibocytes releases meibum via a small canal
(ductule) to a central excretory duct that opens at the lid
margin near the mucocutaneous junction. To maintain meibum
production and secretion continuously, the meibocytes are
constantly undergoing renewal that is sustained by division of
the basal cells in the peripheral acinus. Our current data from
the control mice (Fig. 7) also support such a notion on MG
homeostasis. However, how does FGFR2 signaling control MG
homeostasis at cellular level? Our findings in the Fgfr2CKO mice
with Dox-induced MG atrophy suggest that cell proliferation
markers, including PCNA expression and BrdU incorporation,
are drastically reduced in the MG acinar basal cells (Fig. 7).
Deletion of FGFR2 induced by Dox results in the loss of MG
acinar basal cells, as shown by the number of p63-expressing
cells (Fig. 7B) and disruption of the continuous replenishment
of meibocytes and regeneration of MG clusters, thus leading to
MG atrophy. This finding further suggests that FGFR2 signaling
plays an essential role in maintaining acinar basal cell
proliferation in MGs. Alternatively, it is also possible that
FGFR2 activity is required for the maintenance of MG acinar
progenitor/stem cell population, which was recently demon-
strated by Parfitt et al.37 Dox-induced FGFR2 deletion may
result in a depletion of MG acinar progenitor cells in Fgfr2CKO
mice. Nonetheless, whether FGFR2-signaling activity plays a
similar role in human MGs and whether such activity is altered
in aged human MGs await further investigation.
In obstructive MGD, hyperkeratinization of the MG orifice is
thought to lead to cystic ductal dilation and downstream disuse
atrophy of the MG acini.7,31,38,39 However, ductal hyperkera-
tinization was not observed in a mouse model of age-related
MGD.24 In our current mouse model, we did not see ductal
dilation in Fgfr2CKO mice, and the K16 and K10 expression
patterns were not affected by MG atrophy (Fig. 6). By
immunofluorescence, a low level of FGFR2 was still detectable
in MG ductal epithelial cells in Fgfr2CKO mice fed Dox for 6
days (data not shown). The differential deletion efficiency
between MG acinar and ductal cells potentially could result
from a higher FGFR2 level (Fig. 1B) and a slower cell turnover
rate in ductal epithelial cells than in acinar meibocytes.37
However, the acellular areas (indicative of meibum volume) in
MG ducts were visibly reduced, and the pyknotic nuclei were
increased in the ductules and central ducts of Fgfr2CKO mice
(Figs. 5–7). These observations suggest that meibocyte
differentiation and maturation was compromised in Fgfr2CKO
mice. We speculate that such an accumulation of cellular/
nuclear debris in the ductal system could be a contributing
factor, eventually leading to pathogenic ductal obstruction.
Clinically, MGD is often associated with an inflammatory
response. The causal relationship between MGD and inflam-
mation remains somewhat debatable.9,40 In our Fgfr2CKO
mouse model, inflammation was not readily evident when
the mutant mice developed severe MG atrophy after 2 weeks of
Dox treatment (Fig. 3D). Because Dox has been shown to have
anti-inflammatory effects and is frequently used clinically for
treating MGD,41,42 it is possible that Dox is suppressing
inflammation in the Fgfr2CKO mice. Alternative conditional
deletion systems have been investigated,43 and we are
currently breeding another transgenic model using tamoxifen
(instead of Dox) to turn on Cre expression. Nonetheless, we
can take advantage of our current Dox inducible model to
explore the pathogenic mechanisms of glandular atrophy in
MGD independent of inflammation-mediated pathways.
Conventionally, DED is often considered to be a disorder of
tear film, accompanied by changes in several ocular surface
tissues, including the conjunctiva, goblet cells and corneal
epithelium.44–46 Similar to MGs, these ocular surface epithelial
tissues also express Krt14 and are subject to FGFR2 deletion in
our mouse model. However, the deletion efficiency varies
among these tissues, depending on several factors such as the
K14-promoter activity level, accessibility to Dox, and cell
turnover rate. When FGFR2 protein level was examined by
immunofluorescence in ocular surface tissues of Fgfr2CKO mice
fed with Dox for 10 days, the signal intensity was reduced but
still detectable in conjunctival and corneal epithelial cells (data
not shown). In this study, we could not examine whether
prolonged Dox exposure results in complete depletion of
FGFR2 in these tissues, because the general health of Fgfr2CKO
mice started to deteriorate after 2 weeks of feeding with Dox.
When conjunctival epithelia of control mice and Fgfr2CKO
mice fed with Dox chow for 2 weeks were carefully examined
by histology, we did not observe any major changes in cell
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morphology or goblet cell density (Fig. 4; Supplementary Fig.
S1). However, the corneal epithelial layer of Fgfr2CKO mice was
notably thinner than that of control mice (Fig. 4D, pointed out
by arrows). Because corneal surface damage can occur in MGD
patients,45 the corneal changes in Fgfr2CKO mice could be
secondary to the severe MG atrophy induced after 2 weeks of
Dox feeding. Alternatively, corneal epithelial cells can be
directly affected by FGFR2 deletion, as we have previously
shown that FGFR2 plays a critical role in control of cell
proliferation during early corneal development.47 To further
explore whether FGFR2 is directly involved in maintaining
normal corneal epithelium homeostasis, an inducible Cre
system driven by the cornea-specific Krt12 promoter can be
used in future studies to eliminate confounding factors such as
the interference from eyelids and other ocular surface
tissues.48
In conclusion, our novel mouse model with conditional
deletion of FGFR2 clearly demonstrates that the FGFR2-
signaling pathway is critical for MG maintenance and
homeostasis in adult mice. Because human MGs also express
high levels of FGFR2 and because MGD is the most common
cause of evaporative DED, it would be exciting to further
substantiate that age-related MG atrophy and glandular
dropouts in aging humans are a result of deficient FGFR2
signaling. Understanding the underlying mechanism of MGD
can potentially lead to the development of effective manage-
ment of this condition. The animal model of MG atrophy we
developed not only should allow us to elucidate a previously
unexplored disease process, but would also facilitate the
development of novel therapeutic strategies specific for MGD,
such as modulation of FGFR2 signaling in MGs and ocular
surface tissues.
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